• Yohei Ohtani MD, PhD, Hideaki Tani MD, PhD, Kie Nomoto-Takahashi MD, Taisuke Yatomi MD, Kengo Yonezawa MD, Sota Tomiyama MA, Nobuhiro Nagai MD, PhD, Keisuke Kusudo MD, Shiori Honda MS, PhD, Sotaro Moriyama MD, Shinichiro Nakajima MD, PhD, Takashige Yamada MD, PhD, Hiroshi Morisaki MD, PhD, Yu Iwabuchi MD, PhD, Masahiro Jinzaki MD, PhD, Kimio Yoshimura MD, PhD, Tsuyoshi Eiro MD, PhD, Sakiko Tsugawa MD, Sadamitsu Ichijo MD, PhD, Yu Fujimoto MD, Tomoyuki Miyazaki MD, PhD, Takuya Takahashi MD, PhD, Hiroyuki Uchida MD, PhD
  Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial
  Psychiatry and Clinical Neurosciences. doi:10.1111/pcn.13734 Aug 30, 2024.